Facing the Reality of Drug-Resistant Tuberculosis in India
National Academies Press (Verlag)
978-0-309-21966-2 (ISBN)
The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop.
Table of Contents
Front Matter
1 Introduction
2 Drug-Resistant TB in India
3 The Global Burden of Drug-Resistant TB
4 Preventing Transmission of Drug-Resistant TB
5 Detecting Drug Resistance and Strengthening Laboratory Capacity
6 Addressing TB and Drug-Resistant TB in Vulnerable Populations
7 Combating Drug-Resistant TB Through Public–Private Collaboration and Innovative Approaches
8 Confronting Challenges to the Supply Chain for SecondLine Drugs
9 Creating a Blueprint for Action
References
Appendix A: Workshop Agenda
Appendix B: Summary of a Joint Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Indian Biomedical Research Agencies, Held April 20-21, 2011, New Delhi, India
Appendix C: Participant Biographies
1 Front Matter; 2 1 Introduction; 3 2 Drug-Resistant TB in India; 4 3 The Global Burden of Drug-Resistant TB; 5 4 Preventing Transmission of Drug-Resistant TB; 6 5 Detecting Drug Resistance and Strengthening Laboratory Capacity; 7 6 Addressing TB and Drug-Resistant TB in Vulnerable Populations; 8 7 Combating Drug-Resistant TB Through PublicPrivate Collaboration and Innovative Approaches; 9 8 Confronting Challenges to the Supply Chain for SecondLine Drugs; 10 9 Creating a Blueprint for Action; 11 References; 12 Appendix A: Workshop Agenda; 13 Appendix B: Summary of a Joint Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Indian Biomedical Research Agencies, Held April 20-21, 2011, New Delhi, India; 14 Appendix C: Participant Biographies
Verlagsort | Washington |
---|---|
Sprache | englisch |
Maße | 152 x 229 mm |
Themenwelt | Studium ► Querschnittsbereiche ► Infektiologie / Immunologie |
Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
ISBN-10 | 0-309-21966-3 / 0309219663 |
ISBN-13 | 978-0-309-21966-2 / 9780309219662 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich